Lyra Therapeutics, Inc. (LYRA) Total liabilities 2021–2025
Lyra Therapeutics, Inc. (LYRA) total liabilities at each fiscal year-end, per SEC filings.
$46.8MFY2025 · since FY2021: $20.6M → $46.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $46.8M | -14.5% |
| FY2024 | $54.8M | +3.0% |
| FY2023 | $53.2M | +82.0% |
| FY2022 | $29.2M | +42.2% |
| FY2021 | $20.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice